In addition, we found that the BMP targets, ID1 and ID2, were significantly downregulated in the carcinomas, whereas GREM1 and NOG expression increased, albeit not significantly in the case of GREM1 (Fig. 7d). The gene discussed is ID1; the disease is carcinoma.